Cytopathies involving mitochondrial complex II

被引:70
作者
Ackrell, Brian A. C. [1 ]
机构
[1] Dept Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0098-2997(02)00012-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complex II (succinate-ubiquinone oxidoreductase) is the smallest complex in the respiratory chain and contains four nuclear-encoded subunits SdhA, SdhB, SdhC, and SdhD. It functions both as a respiratory chain component and an essential enzyme of the TCA cycle. Electrons derived from succinate can thus be directly transferred to the ubiquinone pool. Major insights into the workingks of complex II have been provided by crystal structures of closely related bacterial enzymes, which have also been genetically manipulated to answer questions of structure-function not approachable using the mammalian system. This information, together with that accrued over the years on bovine complex II and by recent advances in understanding in vivo synthesis of the non-heme iron co-factors of the enzyme, is allowing better recognition of improper functioning of human complex II in diseased states. The discussion in this review is thus limited to cytopathies arising because the enzyme itself is defective or depleted by lack of iron-sulfur clusters. There is a clear dichotomy of effects. Enzyme depletion and mutations in SDHA compromise TCA activity and energy production, whereas mutations in SDHB, SDHC, and SDHD induce paraganglioma. SDHC and SDHD are the first tumor suppressor genes of mitochondrial proteins. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:369 / 384
页数:16
相关论文
共 91 条
  • [1] Ackrell B.A. C., 1992, CHEM BIOCH FLAVOENZY, VIII, P229
  • [2] Progress in understanding structure-function relationships in respiratory chain complex II
    Ackrell, BAC
    [J]. FEBS LETTERS, 2000, 466 (01): : 1 - 5
  • [3] ACKRELL BAC, 1984, J BIOL CHEM, V259, P53
  • [4] GENETICS AND MOLECULAR-BIOLOGY OF HUNTINGTONS-DISEASE
    ALBIN, RL
    TAGLE, DA
    [J]. TRENDS IN NEUROSCIENCES, 1995, 18 (01) : 11 - 14
  • [5] Germline SDHD mutation in familial phaeochromocytoma
    Astuti, D
    Douglas, F
    Lennard, TWJ
    Aligianis, IA
    Woodward, ER
    Evans, DGR
    Eng, C
    Latif, F
    Maher, ER
    [J]. LANCET, 2001, 357 (9263) : 1181 - 1182
  • [6] Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
    Astuti, D
    Latif, F
    Dallol, A
    Dahia, PLM
    Douglas, F
    George, E
    Sköldberg, F
    Husebye, ES
    Eng, C
    Maher, ER
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (01) : 49 - 54
  • [7] Promoter analysis of the human succinate dehydrogenase iron-protein gene - Both nuclear respiratory factors NRF-1 and NRF-2 are required
    Au, HC
    Scheffler, IE
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (1-2): : 164 - 174
  • [8] Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
    Babcock, M
    deSilva, D
    Oaks, R
    DavisKaplan, S
    Jiralerspong, S
    Montermini, L
    Pandolfo, M
    Kaplan, J
    [J]. SCIENCE, 1997, 276 (5319) : 1709 - 1712
  • [9] Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss
    Badenhop, RF
    Cherian, S
    Lord, RSA
    Baysal, BE
    Taschner, PEM
    Schofield, PR
    [J]. GENES CHROMOSOMES & CANCER, 2001, 31 (03) : 255 - 263
  • [10] Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
    Baysal, BE
    Ferrell, RE
    Willett-Brozick, JE
    Lawrence, EC
    Myssiorek, D
    Bosch, A
    van der Mey, A
    Taschner, PEM
    Rubinstein, WS
    Myers, EN
    Richard, CW
    Cornelisse, CJ
    Devilee, P
    Devlin, B
    [J]. SCIENCE, 2000, 287 (5454) : 848 - 851